FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

317484007: Senna+ispaghula 12.4%/54.2% granules (product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    461895019 Senna+ispaghula 12.4%/54.2% granules en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1188107012 Senna+ispaghula 12.4%/54.2% granules (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    2693896015 Senna fruit 12.4% / Ispaghula 54.2% granules en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    4729021000005111 sennes 12,4 % + loppefrø 54,2 % granulat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    sennes 12,4 % + loppefrø 54,2 % granulat Is a Product containing senna (medicinal product) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Senna (substance) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat Is a Product containing psyllium and senna (medicinal product) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ispaghula husk (substance) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat Has manufactured dose form A solid dose form consisting of dry aggregates of powder particles that are sufficiently resistant to withstand handling. false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Antilipemic agent (substance) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat Has manufactured dose form Oral granules false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat Is a Senna-containing product in oral dose form false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Psyllium (substance) false Inferred relationship Some
    sennes 12,4 % + loppefrø 54,2 % granulat Is a TEMPORARY parent for CDs that are not updated false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start